NCT01491386View on ClinicalTrials.gov

Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease

NACompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Degenerative Disc Disease
Interventions
DEVICE

rhBMP-2/ACS/LT-CAGE® Device

LT-CAGE® device with recombinant human bone morphogenetic protein-2 ( rhBMP-2) and the absorbable collagen sponge (ACS).

DEVICE

Autogenous Bone/LT-CAGE® Device

LT-CAGE® device with autogenous bone taken from the iliac crest.

All Listed Sponsors
lead

Medtronic Spinal and Biologics

INDUSTRY

NCT01491386 - Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease | Biotech Hunter | Biotech Hunter